(CD5) Amundi Index Solutions - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU1681047319 • Eurozone Large-Cap Equity
CD5: Equities, Stocks, Index, Tracking, Europe
Amundi Index Solutions - Amundi EURO STOXX 50 UCITS ETF-D EUR (Ticker: CD5) is an exchange-traded fund designed to replicate the performance of the EURO STOXX 50 Index, a widely recognized benchmark for large-cap equities in the Eurozone. The fund aims to deliver returns that closely align with the index, minimizing tracking error through a physical replication strategy. As one of the largest ETFs in its category, it provides investors with cost-effective exposure to 50 of the largest and most liquid companies in the Eurozone, spanning sectors such as financials, industrials, and technology. Listed on Euronext Paris, the fund is structured as a UCITS-compliant ETF, ensuring transparency, liquidity, and regulatory compliance for investors across Europe.
With assets under management (AUM) of 891.65 million EUR, the ETF has established itself as a scalable and efficient vehicle for accessing Eurozone large-cap equities. Its design caters to a broad range of investors, from institutional portfolios seeking strategic allocations to individual investors looking for diversified exposure to the European market. The funds low tracking error and competitive expense structure make it a preferred choice for those prioritizing cost efficiency and precision in index replication. Additionally, its listing on a major European exchange ensures ease of trading and accessibility for global investors.
Looking ahead, the Amundi EURO STOXX 50 UCITS ETF-D EUR is well-positioned to benefit from the growing demand for index-based investment solutions. As investors increasingly favor low-cost, passively managed products, the funds ability to deliver precise tracking of the EURO STOXX 50 Index at scale will likely drive further growth in assets. Furthermore, its alignment with the broader trend of European market integration and the increasing adoption of ETFs as core portfolio holdings
Additional Sources for CD5 ETF
CD5 ETF Overview
Market Cap in USD | 902m |
Category | Eurozone Large-Cap Equity |
TER | 0.09% |
IPO / Inception | 2018-02-14 |
CD5 ETF Ratings
Growth Rating | 71.4 |
Fundamental | - |
Dividend Rating | 68.9 |
Rel. Strength | -3.81 |
Analysts | - |
Fair Price Momentum | 81.74 EUR |
Fair Price DCF | - |
CD5 Dividends
Dividend Yield 12m | 2.79% |
Yield on Cost 5y | 5.54% |
Annual Growth 5y | 13.65% |
Payout Consistency | 92.1% |
CD5 Growth Ratios
Growth Correlation 3m | -20.6% |
Growth Correlation 12m | 40.4% |
Growth Correlation 5y | 91% |
CAGR 5y | 14.55% |
CAGR/Max DD 5y | 0.62 |
Sharpe Ratio 12m | 0.66 |
Alpha | -3.61 |
Beta | 0.592 |
Volatility | 36.01% |
Current Volume | 0k |
Average Volume 20d | 9.7k |
As of April 22, 2025, the stock is trading at EUR 78.40 with a total of 0 shares traded.
Over the past week, the price has changed by +0.59%, over one month by -8.62%, over three months by -3.95% and over the past year by +2.94%.
Yes. Based on ValueRay Analyses, Amundi Index Solutions (PA:CD5) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 71.43 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CD5 as of April 2025 is 81.74. This means that CD5 is currently overvalued and has a potential downside of 4.26%.
Amundi Index Solutions has no consensus analysts rating.
According to ValueRays Forecast Model, CD5 Amundi Index Solutions will be worth about 89.5 in April 2026. The stock is currently trading at 78.40. This means that the stock has a potential upside of +14.11%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 89.5 | 14.1% |